sulofenur has been researched along with Cancer of Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, R; Hatty, S; Kamthan, A; Peters, B; Scarffe, JH; Smyth, JF; Walling, J | 1 |
| Hamada, K; Inoue, K; Mukaiyama, T; Ogawa, M; Shibata, H; Wang, Y | 1 |
1 trial(s) available for sulofenur and Cancer of Esophagus
| Article | Year |
|---|---|
A phase II study of sulofenur (LY186641) in gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Sulfonylurea Compounds | 1992 |
1 other study(ies) available for sulofenur and Cancer of Esophagus
| Article | Year |
|---|---|
[Antitumor activity of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea, LY 186641 against various human cancers using subrenal capsule assay].
Topics: Antineoplastic Agents; Colorectal Neoplasms; Esophageal Neoplasms; Humans; Lymphoma; Neoplasms; Subrenal Capsule Assay; Sulfonylurea Compounds | 1990 |